Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
BCG Bacillus Calmette Guerin unspecified | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
BCG Bacillus Calmette Guerin unspecified | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
BCG Bacillus Calmette Guerin unspecified | est un(e) (attribut) | Bacillus Calmette-Guerin antigen only vaccine product | true | Inferred relationship | Some | ||
BCG Bacillus Calmette Guerin unspecified | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
BCG Bacillus Calmette Guerin unspecified | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
BCG Bacillus Calmette Guerin unspecified | a pour principe actif (attribut) | Bacillus Calmette-Guerin antigen | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) | est un(e) (attribut) | True | BCG Bacillus Calmette Guerin unspecified | Inferred relationship | Some | |
BCG vaccin IDM | est un(e) (attribut) | True | BCG Bacillus Calmette Guerin unspecified | Inferred relationship | Some | |
BCG Freeze-dried Glutamate BCG Vaccine (Japan) 0.5 microgram per milliliter powder and diluent for suspension for injection Japan BCG Laboratory (real clinical drug) | est un(e) (attribut) | True | BCG Bacillus Calmette Guerin unspecified | Inferred relationship | Some |
Reference Sets
Historical name codes for vaccines reference set (foundation metadata concept)